Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 13, 2013

View Archived Issues

Final results presented for glioblastoma multiforme trial of Cotara

Results from ongoing VAL-083 brain cancer trial

DS-5272 as a novel Hdm2 inhibitor for the treatment of relapsed and/or refractory MM

Otlertuzumab combined with rituximab shows promise in lymphocytic leukemia

Avanir releases results from phase II PRIME study

Ono and Receptos expand collaboration with GPCR technology platform transfer

Myriad Genetics forms research collaboration with Janssen Research & Development

Johnson & Johnson collaborates with Canadian early-stage drug technology centers

KU Leuven and Biocartis to develop diagnostic test for MMR-deficient cancer

CytRx reports data from global phase IIb trial of aldoxorubicin

Ario Pharma founded to develop therapies for respiratory indications

Novel fusion protein provides hope for hemophilia sufferers

to-BBB and Sihuan Pharmaceutical collaborate on treatments for CNS diseases

Abstral launched in Japan

MER-TIK, a novel tyrosine-protein kinase Mer inhibitor demonstrating antileukemic activity

C4 Imaging receives FDA 510(k) clearance for Sirius

E.U. funding for iHIVARNA program of HIV therapeutic vaccine

Bayer Schering Pharma patents novel sGC activators for cardiovascular disorders

Researchers at Bayer Schering Pharma present novel Mnk1 inhibitors

Venantius discloses new agents for IBD

Novel compounds for influenza prepared by European researchers

Ono Pharmaceutical synthesizes novel coagulation factor XIa inhibitors

Agents for HCV infection disclosed by Janssen R&D Ireland

Roche and Prothena collaborate on antibodies for Parkinson's disease

FDA committee recommends approval of metreleptin for generalized lipodystrophy

AstraZeneca presents novel FGFR-4 inhibitor with promising activity against HCC

Medivir begins phase IIa study combining simeprevir, TMC-647055 and JNJ-56914845

Agios Pharmaceuticals extends cancer metabolism collaboration with Celgene

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...